Why Do Pharmaceutical Companies Outsource Fill Finish

 

Fill-finish operations are still one of the most widely outsourced biopharmaceutical production tasks.

Fill and finish activities allow a product to be sterilely filled and sealed into end-use containers. Fill and finish operations are especially crucial for filled vials, syringes, cartridges, and other medical-grade goods because they ensure that the correct amount of pure and contaminant-free substance is consistently added and sealed.

Fill-finish procedures have long been one of the most typical biopharmaceutical manufacturing tasks to be outsourced.

Over recent years, the worldwide pharmaceutical fill-finish outsourcing market has been expected to be driven by rising demand for biopharmaceuticals. Biotechnology and pharmaceutical businesses outsource goods to contract manufacturing groups to meet their needs and lower the risk element. Large corporations outsource at least a portion of their fill-and-finish requirements to reduce supply chain risks.

 Fill and finish tasks are outsourced because they require skilled labor, costly automated equipment acquisitions, cleanroom setup, monitoring, and certifications. In addition, each filling and finishing task necessitates using specialized processes, equipment, and personnel. It is far more cost-effective for most products to outsource sterile filling and finishing procedures rather than invest in an in-house system.

Due to the equipment, cleanrooms, and trained employees required for such specialized tasks, the combination of fill finish processes is one of the most widely outsourced biopharmaceutical production activities. Indeed, when placed into their final product containers, medical-grade cosmetics, biopharmaceuticals, and other medical-grade products require special handling and practices to assure sterility and safety.

Inappropriate in-house filling for biological and pharmaceutical goods generated from high-cost raw materials (or procedures) is costly to repair, and most pharmaceutical and medical device businesses do not want to take the risk. The cost of installing specialized equipment and recruiting trained personnel merely to fill one product isn't worth it.

Almost 75% of bio manufacturers outsource some or all of their filling and finishing operations. Furthermore, out of the top twenty-four outsourced biomanufacturing activities, filling and finishing processes rank fourth, ahead of toxicity testing.

Are Filling and Finishing Activities Becoming More Automated?

Because human interaction is one of the most significant sources of contamination throughout any manufacturing process, most aseptic filling activities are highly automated.

Raw materials loading, system changeovers (such as those required for prefilled syringes), and cleaning are all automated processes. Robotics and automation advancements have made it possible to automate and change operations with greater efficiency and convenience.

Conclusion

Filling and finishing activities allow a product to be filled and sealed into end-use containers with sterility and precision. Fill and finish procedures are especially crucial for filled vials, syringes, cartridges, and other medical-grade goods because they ensure that the correct amount of sterile and contaminant-free product is regularly added and sealed.

Filling and finishing activities and operations are the fourth most heavily outsourced biomanufacturing activity, and this trend is projected to continue or develop in the future. Are you looking for a professional fill and finishing company or want to know more about our fill finish manufacturing services? Contact us today.